Physician

Deirdre Ann Reid-Fighera, M.D.

According to 2025 Medicare claims, Deirdre Reid-Fighera, M.D. (NPI: 1841220662) practices rheumatology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TRI-COUNTY RHEUMATOLOGY, LLC (NPI: 1033311840; TIN: 260196768) and primary practice location at 19046-8001.

Reid-Fighera's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 396 traditional Medicare patients, billed 122,751 HCPCS/CPT codes, and received $1,397,177 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,998 prescription claims across 377 beneficiaries totaling $2,753,056 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 10 records totaling $209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $590,923 to $1,397,177. Similarly, Part D prescription costs have moved sharply higher in recent years, from $637,888 to $2,753,056. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	205	32,386	$590,923
2016	206	30,390	$727,213
2017	263	40,445	$813,816
2018	274	37,633	$1,094,226
2019	293	50,613	$1,296,900
2020	301	67,882	$1,145,454
2021	313	68,403	$1,053,272
2022	317	105,871	$1,190,522
2023	367	124,002	$1,358,267
2024	396	122,751	$1,397,177

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	251	2,913	$637,888
2016	243	2,827	$877,658
2017	268	2,932	$744,739
2018	275	2,978	$1,000,588
2019	285	2,763	$1,119,929
2020	305	2,767	$1,190,746
2021	302	2,643	$1,183,527
2022	338	2,881	$1,772,823
2023	350	2,750	$2,167,436
2024	377	2,998	$2,753,056

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	187	361	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	142	175	$69
J0897	Injection, denosumab, 1 mg	84	8,340	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	160	268	$13
96372	Injection of drug or substance under skin or into muscle	105	392	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	91	3,304	$874,983
Humira(Cf) Pen	Adalimumab	55	1,988	$567,727
Orencia Clickject	Abatacept	39	1,876	$383,297
Rinvoq	Upadacitinib	29	870	$186,259
Cosentyx Sensoready Pen	Secukinumab	13	476	$122,814

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$209	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deirdre Ann Reid-Fighera, M.D.?

Tedicare shows public-source Medicare data for Deirdre Ann Reid-Fighera, M.D. (NPI 1841220662), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deirdre Ann Reid-Fighera, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Deirdre Ann Reid-Fighera, M.D.?

Deirdre Ann Reid-Fighera, M.D. is linked to TRI-COUNTY RHEUMATOLOGY, LLC (billing NPI 1033311840) in the available physician profile data.

Does Deirdre Ann Reid-Fighera, M.D. have Open Payments data?

Deirdre Ann Reid-Fighera, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.